4//SEC Filing
Wiley Matthew T. 4
Accession 0001104659-24-106064
CIK 0001720893other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 9:55 PM ET
Size
7.0 KB
Accession
0001104659-24-106064
Insider Transaction Report
Form 4
Wiley Matthew T.
Other
Transactions
- Award
Common Stock
2024-09-17+21,250→ 25,283 total - Sale
Common Stock
2024-10-03$0.55/sh−6,272$3,450→ 19,011 total
Footnotes (2)
- [F1]The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through October 1, 2024 (the "PSUs"). On September 17, 2024, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 21,250 PSUs had been satisfied and 21,250 shares of common stock became issuable to the Reporting Person on October 1, 2024.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001759703
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 9:55 PM ET
- Size
- 7.0 KB